DPP-4 inhibitor powder active pharmaceutical ingredient for oral antidiabetic tablets. Generic drug developers obtain it for type 2 diabetes formulations emphasizing cardiovascular safety profiles. Provided to tableting operations for incretin-based glycemic control products.